Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial

Bibliographic Details
Title: Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial
Authors: de Bruyn, Guy *, Gordon, David L, Steiner, Theodore, Tambyah, Paul, Cosgrove, Catherine, Martens, Mark, Bassily, Ehab, Chan, Eng-Soon, Patel, Dhaval, Chen, Josh, Torre-Cisneros, Julian, Fernando De Magalhães Francesconi, Carlos, Gesser, Richard, Jeanfreau, Robert, Launay, Odile, Laot, Thelma, Morfin-Otero, Rayo, Oviedo-Orta, Ernesto, Park, Yoon Soo, Piazza, Franco M, Rehm, Christine, Rivas, Enrique, Self, Steve, Gurunathan, Sanjay
Source: In The Lancet Infectious Diseases February 2021 21(2):252-262
Database: ScienceDirect
More Details
ISSN:14733099
DOI:10.1016/S1473-3099(20)30331-5
Published in:The Lancet Infectious Diseases
Language:English